These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34355385)

  • 21. Effect of extremes of body weight on drug level in patient treated with standard dose of rivaroxaban for venous thromboembolism; real life experience.
    Arachchillage D; Reynolds R; Devey T; Maclean R; Kitchen S; van Veen JJ
    Thromb Res; 2016 Nov; 147():32-35. PubMed ID: 27669125
    [No Abstract]   [Full Text] [Related]  

  • 22. Severe dizziness following rivaroxaban introduction in a parkinsonian patient: Drug-drug interaction?
    Lefaucheur R; Le Goff F; Gaillon G; Triquenot-Bagan A; Maltête D
    Presse Med; 2015 Nov; 44(11):1203-4. PubMed ID: 26433836
    [No Abstract]   [Full Text] [Related]  

  • 23. Spontaneous bilateral haemothorax with haemopericardium secondary to rivaroxaban.
    Yu JH; Liu HH; Hsieh MJ; Hsieh IC; Chu PH; Chen DY
    J Clin Pharm Ther; 2020 Oct; 45(5):1175-1178. PubMed ID: 32023350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient adherence to rivaroxaban in deep vein thrombosis, a cohort study in Switzerland: quantitative results.
    Dotta-Celio J; Alatri A; Locatelli I; Salvi M; Bugnon O; Schneider MP; Mazzolai L
    Int J Clin Pharm; 2019 Dec; 41(6):1625-1633. PubMed ID: 31776778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of patients with deep vein thrombosis switched from standard therapy to rivaroxaban in the non-interventional XALIA study.
    Turpie AGG; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Ageno W
    Thromb Res; 2017 Jul; 155():23-27. PubMed ID: 28477534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rivaroxaban Use in Patients with Hemoglobinopathies.
    Apostolou C; Klonizakis P; Mainou M; Kapsali E; Kafantari K; Kotsiafti A; Vetsiou E; Vakalopoulou S; Vlachaki E
    Hemoglobin; 2017 May; 41(3):223-224. PubMed ID: 28950780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of apixaban and rivaroxaban in obese patients with acute venous thrombosis/embolism.
    Anusim N; Ghimire B; Smalley M; Jaiyesimi I; Gaikazian S
    Eur J Haematol; 2022 Oct; 109(4):409-412. PubMed ID: 35739626
    [No Abstract]   [Full Text] [Related]  

  • 28. Rivaroxaban for the treatment of saphenous vein graft thrombosis.
    Marmagkiolis K; Cilingiroglu M
    Rev Port Cardiol; 2016; 35(7-8):447.e1-3. PubMed ID: 27402444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrasound Aspects and Recanalization Rates in Patients with Lower-Limb Deep Venous Thrombosis Treated with Rivaroxaban.
    de Athayde Soares R; Matielo MF; Brochado Neto FC; Almeida RD; Sacilotto R
    Ann Vasc Surg; 2020 Aug; 67():293-299. PubMed ID: 31931131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosing of rivaroxaban by indication: getting the right dose for the patient.
    Escolar G; Carne X; Arellano-Rodrigo E
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1665-77. PubMed ID: 26329812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rivaroxaban for the treatment of cerebral venous thrombosis.
    Mutgi SA; Grose NA; Behrouz R
    Int J Stroke; 2015 Oct; 10 Suppl A100():167-8. PubMed ID: 26502976
    [No Abstract]   [Full Text] [Related]  

  • 32. The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications.
    Raskob GE; Spyropoulos AC; Zrubek J; Ageno W; Albers G; Elliott CG; Halperin J; Haskell L; Hiatt WR; Maynard GA; Peters G; Spiro T; Steg PG; Suh EY; Weitz JI
    Thromb Haemost; 2016 Jun; 115(6):1240-8. PubMed ID: 26842902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early recanalization of veins in patients with DVT treated with rivaroxaban: do we need to move from bedside to bench again?
    Ramacciotti E; Volpiani GG; Dávila R; Resende Aguiar VC; Silveira Magella FM; Fareed J
    Int Angiol; 2018 Feb; 37(1):1-3. PubMed ID: 28945062
    [No Abstract]   [Full Text] [Related]  

  • 34. Rivaroxaban for Fully Occlusive Inferior Vena Cava Filter Thrombus.
    Sakatani A; Nishio M; Kume K; Doi Y; Hirooka K
    Circ J; 2019 Jun; 83(7):1616. PubMed ID: 30726802
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term rivaroxaban for the treatment of acute venous thromboembolism in patients with active cancer in a prospective multicenter trial.
    Yhim HY; Choi WI; Kim SH; Nam SH; Kim KH; Mun YC; Oh D; Hwang HG; Lee KW; Song EK; Kwon YS; Bang SM
    Korean J Intern Med; 2019 Sep; 34(5):1125-1135. PubMed ID: 29788694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral Venous Thrombosis at High Altitude: Analysis of 28 Cases.
    Hassan WU; Syed MJ; Alamgir W; Awan S; Bell SM; Majid A; Wasay M
    Cerebrovasc Dis; 2019; 48(3-6):184-192. PubMed ID: 31775151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.
    Spyropoulos AC; Ageno W; Albers GW; Elliott CG; Halperin JL; Hiatt WR; Maynard GA; Steg PG; Weitz JI; Suh E; Spiro TE; Barnathan ES; Raskob GE;
    N Engl J Med; 2018 Sep; 379(12):1118-1127. PubMed ID: 30145946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial. Rationale and Design of the CASSINI Trial.
    Khorana AA; Vadhan-Raj S; Kuderer NM; Wun T; Liebman H; Soff G; Belani C; O'Reilly EM; McBane R; Eikelboom J; Damaraju CV; Beyers K; Dietrich F; Kakkar AK; Riess H; Peixoto RD; Lyman GH
    Thromb Haemost; 2017 Nov; 117(11):2135-2145. PubMed ID: 28933799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent deep vein thrombosis with rivaroxaban in a patient with metastatic testicular cancer.
    Eid TJ; Kalkat B; Shah SA
    J Pharm Pract; 2015 Jun; 28(3):233. PubMed ID: 25979903
    [No Abstract]   [Full Text] [Related]  

  • 40. Low-molecular-weight heparin followed by rivaroxaban for acute occlusive portomesenteric vein thrombosis in a cirrhotic patient treated with multiple endoscopic variceal procedures.
    Xu X; Guo X; Wang R; Wang L; Li Q; Yi F; Li H; Qi X
    Ann Hepatol; 2020; 19(5):573-577. PubMed ID: 31521463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.